These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 8276368
1. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease. Marcellin P, Samuel D, Areias J, Loriot MA, Arulnaden JL, Gigou M, David MF, Bismuth A, Reynes M, Bréchot C. Hepatology; 1994 Jan; 19(1):6-12. PubMed ID: 8276368 [Abstract] [Full Text] [Related]
3. Recurrence of hepatitis B in liver transplants treated with antiviral therapy. Marzano A, Debernardi-Venon W, Smedile A, Brunetto MR, Torrani Cerenzia MR, Actis GC, Zamboni F, Ghisetti V, Piantino P, David E, Salizzoni M, Rizzetto M. Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):77-81. PubMed ID: 9615271 [Abstract] [Full Text] [Related]
4. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis. Samuel D, Zignego AL, Reynes M, Feray C, Arulnaden JL, David MF, Gigou M, Bismuth A, Mathieu D, Gentilini P. Hepatology; 1995 Feb; 21(2):333-9. PubMed ID: 7843702 [Abstract] [Full Text] [Related]
7. Prognostic significance of the hepatitis B virus-DNA concentration in patients after orthotopic liver transplantation. Zöllner B, Polywka S, Feucht HH, Martens H, Iske L, Oehler G, Laufs R. Hepatogastroenterology; 1994 Oct; 41(5):424-6. PubMed ID: 7851849 [Abstract] [Full Text] [Related]
8. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155 [Abstract] [Full Text] [Related]
9. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation. Flowers M, Sherker A, Sinclair SB, Greig PD, Cameron R, Phillips MJ, Blendis L, Chung SW, Levy GA. Transplantation; 1994 Jul 27; 58(2):183-92. PubMed ID: 8042236 [Abstract] [Full Text] [Related]
12. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation. Chan HL, Chui AK, Lau WY, Chan FK, Wong ML, Tse CH, Rao AR, Wong J, Sung JJ. J Med Virol; 2002 Oct 27; 68(2):182-7. PubMed ID: 12210406 [Abstract] [Full Text] [Related]
13. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation. Ben-Ari Z, Mor E, Shapira Z, Tur-Kaspa R. Liver Transpl; 2001 Feb 27; 7(2):113-7. PubMed ID: 11172394 [Abstract] [Full Text] [Related]
15. [Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation]. Zheng S, Wu J, Wang W, Huang D, Liang T, Lu A. Zhonghua Yi Xue Za Zhi; 2002 Apr 10; 82(7):445-8. PubMed ID: 12133511 [Abstract] [Full Text] [Related]
18. Pilot study of ribavirin and interferon-beta for chronic hepatitis B. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y. Hepatology; 1993 Aug 10; 18(2):258-63. PubMed ID: 8340055 [Abstract] [Full Text] [Related]
19. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation]. Liu J, Wu GC, Zhang ZT, Wu P, Zhang D, Sun MC, Gao DC, Wang Y, Jia JD, Wang BE. Zhonghua Wai Ke Za Zhi; 2005 Aug 01; 43(15):976-9. PubMed ID: 16194352 [Abstract] [Full Text] [Related]
20. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR. Liver Transpl; 2004 Feb 01; 10(2):199-207. PubMed ID: 14762857 [Abstract] [Full Text] [Related] Page: [Next] [New Search]